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Abstract 
For years, the field of drug delivery has focused on (1) controlling the release of a therapeutic 
and (2) targeting the therapeutic to a specific cell type.  These research endeavors have 
concentrated mainly on the development of new degradable polymers and molecule-labeled drug 
delivery vehicles.  Recent interest in biomaterials that respond to their environment have opened 
new methods to trigger the release of drugs and localize the therapeutic within a particular site.  
These novel biomaterials, usually termed “smart” or “intelligent”, are able to deliver a 
therapeutic agent based on either environmental cues or a remote stimulus.  Stimuli-responsive 
materials could potentially elicit a therapeutically effective dose without adverse side effects.  
Polymers responding to different stimuli, such as pH, light, temperature, ultrasound, magnetism, 
or biomolecules have been investigated as potential drug delivery vehicles.  This review 
describes the most recent advances in “smart” drug delivery systems that respond to one or 
multiple stimuli.   
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Introduction   
Polymeric materials that respond to a stimulus are often called “smart" or "intelligent" 
due to their intrinsic ability to alter their physical or chemical properties.  For the majority of the 
polymers that fall into this category, the response to a change in the surrounding environment is 
not only quick, on the order of minutes [1, 2] to hours [3, 4], but also reversible, mimicking the 
dynamics observed in natural polymers, such as proteins, polysaccharides, and nucleic acids in 
living organic systems [5].  The response to stimuli is manifested in many forms: individual 
chain dimension/size, shape, surface characteristics, secondary structure, solubility, and degree 
of intermolecular association.  These unique capabilities have been applied to a diverse range of 
applications, including: drug delivery [4, 6-8], diagnostics [9, 10], biological coating 
technologies [11, 12], biosensing [10, 13], and microfluidics [14].  
Conventional drug delivery methods physically entrap molecules within a polymer 
lattice; drug is released slowly by diffusion or upon degradation of the network.  These methods 
typically result in an early peak in plasma drug concentration followed by a steady, linear 
release.  This is far from ideal because the local drug concentration and location of delivery is 
not precisely controlled.  Below the therapeutic dose, the drug is ineffective whereas high 
concentrations of drug may be toxic or lead to undesirable side effects.  Polymers have been used 
to tailor drug release, which maintains the drug concentration within the desired therapeutic 
range.  However, such controlled release systems are insensitive to metabolic changes in the 
body and are unable to modulate drug release nor target the drug to diseased tissue.  This lack of 
control has motivated the exploitation of bioresponsive polymers as drug carriers.  
As early as the 1950s, stimuli responsive hydrogels have been studied for drug release 
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[15].  Since then, polymers that react to different stimuli have been developed.  These stimuli 
include pH [16-20], ionic strength [21], and the presence of metabolic chemicals (e.g., enzymes 
or antigens) [22, 23].  Such stimuli may enable a drug carrier to distinguish between diseased and 
healthy tissue.  More recently, drug carriers that respond to magnetic fields [24], light [25], 
radiation [26], and ultrasound [27] have also been developed.  These external stimuli allow for 
greater control over when and where the drug is released.  By tuning the formulation or chemical 
moieties of the polymer, the sensitivity to the stimuli can be precisely controlled.  This review 
aims to provide an overview of how responsive polymers may be used to improve drug delivery.   
 
Stimuli-responsive materials for drug delivery  
pH-sensitive drug delivery  
pH-sensitive polymers (see Table 1) have garnered much attention in the fields of drug 
delivery [28, 29], gene delivery [30], and insulin delivery [31].  Generally, pH-sensitive 
polymers have weak acids or bases with pKa values between 3 and 10 [32].  Carboxylic, 
sulfonate, and primary or tertiary amino groups exhibit a change in ionization state as a function 
of pH.  Transitions in solubility, conformation, and swelling arise due to changes in ionization, 
where specific polymer groups switch between a neutral and charged state (e.g., poly(N,N-
dimethylaminoethyl methacrylate (DMAEMA) [33-35]) or a hydrophilic and hydrophobic state 
(e.g., poly(N-iso-propylacrylamide) (PNIPAm) [36-38]).  
Eisenberg et al. investigated pH-sensitive polymer swelling to control the release of drug 
molecules [15].  Since then, several biocompatible and biodegradable pH-sensitive polymers 
have been developed.  Unfortunately, few pH-sensitive polymers have been used for drug 
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delivery systems because of their limited sensitivity near the pH of blood (pH 7.4).   For example, 
natural polymers (alginate [39, 40], chitosan [41, 42], and carrageenan [43]) and synthesized 
polymers (poly(acrylic acid) (AA) [44] and poly(methacrylic acid) (MAA) [45]) exhibit a high 
swelling property at high pH due to ionizable functional groups on the polymer backbone or side 
chain.  These polymers are not responsive under most physiological conditions, albeit the 
gastrointestinal system.          
Systemic delivery requires that drug carriers respond to small changes in pH, near pH 7.4.  
In 2005, Heffernan and Murthy developed an acid-sensitive biodegradable drug delivery vehicle 
using poly(1,4-phenyleneacetone dimethylene ketal) (PPADK), which contains ketal linkages 
allowing for acid-catalyzed hydrolysis of the polymer into low molecular weight hydrophilic 
compounds.  Thus, the release of drug molecules is accelerated under acidic conditions [46].  
You and Auguste synthesized a series of pH-sensitive nanoparticles comprised of DMAEMA 
and 2-hydroxyethyl methacrylate (HEMA) (Figure 1) [3].  DMAEMA is a pH-responsive 
monomer that has a tertiary amine functional group with a pKa of 7.5 [47].  In vitro results 
support that the drug would remain within the particle during circulation; upon exposure to a low 
pH environment (e.g., a tumor [48]), the particle would swell resulting in release of the drug.  
Monodisperse, pH-sensitive DMAEMA/HEMA nanocarriers encapsulating paclitaxel exhibited 
pH-dependent release kinetics (Figure 2).  The particles had a high volume swelling ratio at low 
pH, low crosslinking density, and high content of DMAEMA.  A similar series of particles were 
used for gene delivery, where triggered release of plasmid DNA within the low pH endosome 
was optimized [49, 50].  Plasmid DNA for green fluorescent protein was encapsulated.  HeLa 
cells were successfully transfected with a dependence on the swelling ratio and crosslinking 
density (Figure 3).  
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pH-dependent liposomes have also been used to trigger the release of drug within acidic 
environments.  Auguste et al. formulated liposomes with variable surface charge by varying the 
lipid composition [51].  pH-sensitive liposomes were composed of a zwitterionic lipid 
(phosphatidylcholine) and a titratable lipid (dimethylammonium propane) with a pKa of 6.7.  
This allowed the liposome’s net charge to become cationic upon decreasing the pH.  pH-
dependent liposomes may be shielded from the immune system using poly(ethylene glycol) 
(PEG)-b-polycation polymers.  The polycation block electrostatically anchored the PEG polymer 
to the liposome surface at pH 7.4, but released the polymer at pH 5.5 due to electrostatic 
repulsion between the cationic polymer and cationic liposome surface.  The triggered release of 
adsorbed PEG-b-polycation polymers from pH-dependent liposomes may protect the drug carrier 
from immune recognition during circulation (pH 7.4) and allow subsequent intracellular delivery 
of siRNA within the endosome.  The bare liposome maintains the membrane disruption/fusion 
capability [52, 53]. 
 
Temperature-sensitive drug delivery  
Increases in temperature are associated with several disease states (e.g., cancer [54, 55]).  
Thermo-responsive drug carriers have been employed to release their payload within 
environments above the physiological temperature.  Thermo-sensitive polymers exhibit a phase 
transition in solution at a temperature known as the lower critical solution temperature (LCST).  
For example, PNIPAm, a well-studied thermo-responsive polymer, undergoes a reversible phase 
transition in aqueous solution from hydrophilic to hydrophobic at its LCST of approximately 
32
o
C.  Chemical modifications of PNIPAm have been effective in controlling the LCST [56].  In 
2005, Liu et al. synthesized poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-
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poly(D,L-lactide-co-glycolide) micelles for controlled paclitaxel delivery [36].  Paclitaxel release 
was accelerated when the physiological temperature was raised above the LCST.  The paclitaxel-
loaded micelles were more effective in killing human breast carcinoma cells at 39.5
o
C than 37
o
C.  
De and colleagues developed folate-conjugated, thermo-responsive block copolymer micelles.  
Folate is known to bind to several cancer cell types [57].  The drug release studies from folate-
conjugated PNIPAm-DMA micelles demonstrated a temperature-responsive drug release.  
Delivery of paclitaxel at the tumor site can alter the overall drug biodistribution.  Needham et al. 
developed temperature-sensitive liposomes containing doxorubicin [54].  Their liposome 
formulation, composed of 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (MPPC), 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), hydrogenated soy sn-glycero-3-
phosphocholine (HSPC), and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-polyethylene 
glycol 2000 (DSPE-PEG-2000), was optimized to rapidly release the drug under mild 
hyperthermic temperatures (39
o
C to 40
o
C).  Changing the drug biodistribution can increase 
therapeutic efficacy. 
 
Light-sensitive drug delivery 
Light (ultraviolet or visible) is a desirable external stimulus for drug delivery systems 
because it is inexpensive and easily controlled.  Light-sensitive drug carriers are fabricated from 
polymers that contain photo-sensitizers such as azobenzene, stilbene, and triphenylmethane [37, 
58, 59].  Suzuki and Tanaka have investigated visible light-responsive hydrogels using the 
trisodium salt of copper chlorophyllin in PNIPAm hydrogels [60].  When light is applied to the 
hydrogels, the chromophore absorbs the light, increasing the local temperature of the hydrogel.  
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The resulting temperature change alters the swelling behavior.  Vivero-Escoto et al. prepared 
gold-capped mesoporous silica nanospheres for photo-induced intracellular release of drugs in 
human cells [61].  The 100 nm silica nanospheres were capped with 5 nm gold nanospheres and 
functionalized with a cationic photo-reactive linker.  Photoirradiation using ultraviolet (UV) light 
for 10 min at 0.49 mW/cm
2
 cleaved the photolabile linker, causing uncapping of the silica due to 
charge repulsion between the gold and silica nanospheres, allowing drug to be released [61, 62].  
Fomina et al. developed a novel light-sensitive polymer containing a quinone-methide moiety 
[63].  Nile Red, a hydrophobic dye, was released from nanoparticles after only one minute of 350 
nm light exposure.  Light can be effective in modulating drug release because it can be used to 
increase the local temperature and to cleave bonds. 
 
Ultrasound-sensitive drug delivery 
Ultrasound has been shown to trigger drug release by raising the local temperature or 
causing cavitation [64].  Both processes can increase the permeability of cell membranes and 
accelerate polymer degradation [65].  Ultrasound-sensitive vehicles have the potential to treat 
tumorigenic cancers due to their invasive character, ability to penetrate deeply into the human 
body, and ease of control.  In 2002, Pruitt and Pitt investigated ultrasound-mediated doxorubicin 
release using stabilized Pluronic P105 micelles [66].  Doxorubicin was encapsulated within 
polymeric micelles composed of 10% Pluronic P105 and N,N-diethylacrylamide and delivered 
systemically to rats.  Application of low-frequency ultrasound at the tumor site resulted in 
doxorubicin release; this resulted in a significant reduction in tumor volume.  Lin et al. have 
investigated the physical and chemical properties of lipid membranes subjected to ultrasound 
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treatment [67].  They showed that high permeability resulting from ultrasound treatment is 
correlated with lipid packing and can be useful for efficient drug release and ultrasound-
mediated DNA transfection.  In 2007, Ferrara et al. reviewed that small gas bubbles, used to 
enhance ultrasound contrast, can be used for drug delivery applications and monitoring [68].  
When driven by an ultrasonic pulse, small gas bubbles oscillate with a wall velocity on the order 
of tens to hundreds of meters per second and can be deflected to a vessel wall or fragmented into 
particles on the order of nanometers.  Also, a focused ultrasound beam can be used for disruption 
of delivery vesicles and blood vessel walls, which offer the opportunity to locally deliver a drug 
or gene.  Ultrasound does not damage the surrounding tissue, making it attractive for triggering 
drug release. 
 
Biomolecule-responsive drug delivery 
 The presence of biomolecules specific to an organ or disease state may be useful to 
regulate the release of drugs.  Biomolecules can either participate in a chemical reaction or result 
in cleavage of a chemical bond.  In this section, we will discuss the use of hydrogels that are (1) 
responsive to glucose and (2) use enzymes to facilitate hydrogel degradation. 
Glucose-responsive hydrogels have been investigated for self-regulating the release of 
insulin for the treatment of diabetes.  Early studies have been largely based on the combination 
of glucose oxidase with polyelectrolyte hydrogels that exhibit pH-responsive swelling or 
shrinking behavior [69, 70].  As glucose diffuses within the hydrogel, entrapped glucose oxidase 
catalyzes its conversion to gluconic acid, lowering the local pH of the gel and resulting in 
swelling and the subsequent release of insulin.  However, the efficiency of glucose oxidase 
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decreases with pH.  PNIPAm coupled with phenylboronic acid has been investigated as a 
glucose-responsive system [71, 72].  Introduction of phenylboronic acid decreases the volume 
phase transition temperature.  The hydrogel swells in the presence of glucose.  More recently, 
Miyata et al. demonstrated that biomolecular complexes such as the carbohydrate-binding lectin, 
concanavalin A (Con. A), could be coupled with PNIPAm to achieve reversible swelling or 
shrinking in response to stepwise changes in glucose concentration [73].  Zhang et al. also 
utilized Con. A as the cross-linker for carboxymethyl dextran (CM-dextran) based hydrogels.  
Competitive displacement between Con. A and terminal glucose moieties on dextran by free 
glucose changed both the morphology and permeability of the gel [74].  Although these systems 
triggered insulin release through volumetric changes, regulating the rate and reliability of release 
remains a challenge.  
Researchers have also exploited the presence of site or disease specific enzymes in drug 
delivery by incorporating enzyme-cleavable peptides within hydrogels.  For example, Aimetti et 
al. prepared a PEG hydrogel drug delivery system which incorporated human neutrophil elastase 
(HNE)-sensitive linkers for the treatment of inflammation.  HNE is a serine protease secreted by 
neutrophils, which accumulates at sites of inflammation.  HNE-sensitive peptides were 
synthesized using solid phase Fmoc chemistry and their degradation kinetics were characterized. 
The rate of substrate degradation can be tailored by the incorporation or substitution of specific 
amino acids.  Local, controlled release from hydrogels containing HNE-sensitive peptides was 
achieved in the presence of HNE as visualized by fluorescence energy resonance transfer 
(FRET) [75].   
 Growth factor delivery, controlled by enzymes involved in tissue regeneration, has also 
been investigated.  Sakiyama-Elbert et al. designed the delivery of beta-nerve growth factor (β-
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NGF) from fibrin matrices as a nerve regeneration therapy.  They synthesized β-NGF fusion 
proteins with an enzymatically degradable linker that served as the covalent anchor to the fibrin 
matrix and thus prevented a potential loss of enzymatic activity [76].  Researchers have also 
exploited the enzyme-triggered degradability of certain prodrugs.  Pedersen et al. investigated 
anti-cancer retinoid lipophilic drugs that are covalently attached to phospholipids.  These 
prodrugs have a lipid backbone that is degradable by secretory phospholipase A2 (sPLA2) IIA.  
The prodrugs self-assembled into liposomes, which were susceptible to degradation by (sPLA2) 
IIA.  In vitro studies utilizing MT-3 breast carcinoma and HT-29 colon adenocarcinoma cell 
lines demonstrated high cytotoxicity of prodrug liposomes only in the presence of the (sPLA2) 
IIA enzyme [77].  
 
Magnetic-sensitive drug delivery 
 Magnetic drug delivery systems possess three main advantages: (1) visualization of drug 
delivery vehicles, (2) ability to guide and control movement of drug carriers through magnetic 
fields, and (3) thermal heating which has been used to control drug release or produce tissue 
ablation.  Magnetic drug carriers like magnetite, maghemite, cobalt ferrite, and carbonyl iron are 
biocompatible, non-toxic and non-immunogenic [78].  Arias et al. utilized magnetite to produce 
magnetic core/shell nanoparticles for drug delivery.  The nanoparticles consisted of a magnetite 
core with a self-assembling squalenoyl gemcitabine, an amphiphilic anti-cancer drug, shell.  
Optical microscopy images showed the alignment of the core/shell nanoparticles under the 
influence of a 0.2 T magnetic field [78].  Liu et al. reported in vitro and in vivo studies of 
poly[aniline-co-N-(1-one-butyric acid)] aniline (SPAnH) nanoparticles encapsulating iron oxide 
(Fe3O4).  To overcome the blood-brain barrier, the authors utilized focused ultrasound to 
12 
 
temporarily disrupt the barrier and increase permeability.  Their results showed that an estimated 
0.16 ± 0.03 mM of magnetic nanoparticles were delivered to brain tumors in Sprague-Dawley 
rats; this was estimated to be 15-fold higher than the therapeutic range [79].  Magnetic 
nanoparticles have also been proposed as a component in drug eluting stents for the treatment of 
vascular diseases.  Chorny et al. reported the use of polylactide nanoparticles incorporating 
magnetite nanocrystals and encapsulating paclitaxel.  In vitro studies demonstrated cell growth 
inhibition with a relatively low dose and brief (five minute) magnetic field exposure.  In vivo 
studies performed in a rat carotid artery model of stent restenosis showed a significant benefit 
over the control group. Additionally, 13.2 ± 2.0 μg of magnetic nanoparticles delivered to the 
stented carotid segment under a magnetic field were retained in the artery compared to only 3.4 ± 
1.9 μg of particles delivered without a magnetic field [80].   
 Magnetic nanoparticles have also been encapsulated within liposomes.  da Silva Gomes 
et al. synthesized liposomes encapsulating magnetic nanoparticles with an outer polyelectrolyte 
shell using a layer by layer deposition technique.  The lipid vesicles were characterized by 
dynamic light scattering, cryo-transmission electron microscopy and atomic force microscopy. 
Polyelectrolyte coated-liposomes were highly stable as they showed no significant membrane 
disruption or leakage of encapsulated contents in the presence of detergent Triton TX-100 [81].   
 
Multiple responsive-matrices in drug delivery 
Substantial benefits may be gained from the development of polymeric macromolecules 
that are responsive to small environmental changes and consequently elicit a response.  Despite 
the many advances that have been accomplished, the field of stimuli-responsive biomaterials still 
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faces many challenges.  Most of the “smart” materials that have been investigated are primarily 
focused on a single type of stimulus.  Developing a material that is responsive to more than one 
stimulus may combine the delivery of a drug with other capabilities such as detection, imaging, 
or feedback.  Attention has been focused on materials that respond to more than one stimulus 
(Table 2).  
 
Temperature- and pH-responsive matrices  
Temperature- and pH-responsive matrices have been extensively studied in drug delivery 
because these two parameters often deviate from the norm in diseased tissue.  Both 
environmental changes offer the ability for self-regulated control over the delivery of a drug, 
avoiding the need for external stimuli.  Poly(N-isopropylacrylamide-co-methacrylic acid) and 
PNIPAm are well-established thermo-responsive polymers [6, 38, 82-94].  These polymers may 
be combined with pH-responsive polymers, like AA and its alkyl esters such as MAA [6, 82, 85, 
94, 95].  Zhang et al. prepared temperature and pH-responsive nanoparticles from combinations 
of PNIPAm and MAA at different molar ratios [82].  The relative permeability of the 
nanoparticles increased significantly when the temperature was increased from 37°C to 43°C and 
when the pH decreased from 6 to 4.  Nanoparticles encapsulating vitamin B12 exhibited a 
partition coefficient that decreased from 0.8 to 0.3 with increasing temperature and decreased 
from 0.8 to 0.6 with decreasing pH.  Gu et al. prepared PNIPAm-co-AA hydrogels with hollow 
“cages” [6].  They showed that isoniazid (INH), an antitubercular drug, was located inside the 
cavity of the gel “cages” and also within the shell.  The “cages,” which were synthesized by 
SiO2-templated polymerization, had a silica core that was subsequently etched away by 
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hydrofluoric acid leaving a hollow interior.  The hydrodynamic diameter of the hydrogel “cages” 
decreased from 367 nm to 200 nm with increasing temperature and decreasing pH.  Salehi et al. 
synthesized an injectable hydrogel system composed of PNIPAm, acrylamide (AAm), and vinyl 
pyrrolidone (VP) to encapsulate naltrexone, an opiate receptor antagonist [94].  The swelling 
ratios of the gel increased when the pH decreased from 8.5 to 7.4 and decreased when the 
temperature increased from 25°C to 37°C.  They also performed in vitro release studies where a 
low burst effect and a slow release profile of naltrexone was observed over the course of 28 
days.   
In addition to PNIPAm, other temperature-responsive polymers have been investigated in 
dual-responsive drug delivery systems [41, 96-100].  Moon et al. prepared and characterized 
amphiphilic, pH- and temperature-responsive polyaspartamide derivatives, which formed 
micelles with an average diameter of 100 nm at 25°C [41].  A sol-gel transition was observed 
when the temperature was increased from 15°C to 25°C and when the pH was increased from 6 
to 10.  Ding et al. fabricated injectable hydrogels based on glycol chitosan and benzaldehyde-
capped poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) (PEO-
PPO-PEO) [98].  In vivo tests using a rat model demonstrated that the hydrogel underwent a sol-
gel transition at physiological conditions.  These hydrogels have the ability to encapsulate both 
hydrophilic and hydrophobic drugs and can control the release profile by varying temperature or 
pH.   
 
Light- and pH- or temperature-responsive matrices 
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Light-responsive materials are combined with a secondary stimulus such as temperature 
or pH to increase control over drug release.  Light responsiveness is usually introduced to a 
temperature or pH-sensitive material by conjugating a photo-reactive moiety [95].  Jochum et al. 
synthesized a thermo- and light-responsive polyacrylamide copolymer having salicylideneaniline 
as a photo-sensitive group [101].  Salicilideneaniline isomerizes from the enol to keto form and 
changes its dipole moment upon exposure to UV light.  To synthesize the polymer, the authors 
performed a double polymer analogous reaction of poly(pentafluorophenyl acrylate) (PPFPA) 
and varied the molar composition of salicylideneaniline from 1 to 15 mol%.   
Light- and pH-responsive materials have also been investigated.  Angelatos et al. 
designed light- and pH-responsive polyelectrolyte/gold nanoparticle microcapsules via the layer 
by layer colloid-templating method [58].  Microcapsules were prepared by depositing the 
electrolytes poly(sodium 4-styrenesulfonate) (PSS) and poly(allylamine hydrochloride) (PAH) in 
a layer by layer fashion onto a template of melamine formaldehyde (MF) microparticles.  The 
MF core was subsequently etched away with hydrochloric acid, and gold nanoparticles were 
introduced into the microcapsule shell.  Fluorescein isothiocyanate (FITC)-dextran was 
encapsulated and was shown to be released after a decrease in pH and upon irradiation of 10 ns 
pulses of light at 1064 nm.   
 
Magnetic- and pH- or temperature-responsive matrices 
Magnetic fields can be remotely applied to localize drug carriers and to induce a 
temperature change.  There have not been an extensive number of studies focusing on magnetic- 
and temperature-responsive materials, but this area has received increasing attention within the 
last few years [102-106].  Luo et al. prepared microspheres by encapsulating silica-coated 
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superparamagnetic magnetite nanoparticle clusters with a crosslinked PNIPAm shell [105].  The 
microspheres exhibited a temperature-dependent swelling ratio; the hydrodynamic diameter 
decreased from 750 nm to 500 nm when the temperature increased from 20°C to 60°C.  
Additionally, the microspheres had greater magnetic responsivity at temperatures higher than the 
volume phase transition temperature due to the decrease in size at higher temperatures.  A faster 
separation-redispersion behavior of the microspheres was observed at 60°C, above the volume 
phase transition temperature, compared to that at 25°C.  In another study, a different 
temperature-responsive material, poly(ethyleneimine)-modified poly(ethylene oxide)-
poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) block copolymer, was used instead 
of PNIPAm to coat iron oxide nanoparticles [102].  The nanoparticle hydrodynamic diameter 
decreased from 45 to 25 nm when the temperature increased from 20°C to 35°C.  One of the 
most attractive features of this drug delivery system is the ability to reversibly control the 
payload release by changing the PEO-PPO-PEO polymer shell conformation.  The polymer shell 
acts as a gate; it is in an extended conformation at room temperature but changes to a coiled 
conformation upon heating to 37°C.  In vitro release of hydrophobic and hydrophilic model 
drugs was achieved by switching the temperature from 37°C to 20°C.  In addition, the 
nanoparticles showed good biocompatibility and effective nerve regeneration when loaded with a 
ganglioside in a spinal cord injury rat model. 
Magnetic- and pH-responsive materials have also been investigated [107-
110].  Superparamagnetic Fe3O4 nanoparticles were coated with different pH-responsive block 
copolymers [109].  Four different block copolymers, methoxypoly(ethylene glycol)-b- (N,N-
diethylamino)ethyl methacrylate-b-poly(glycidyl methacrylate) (MPEG-b-PDEAEMA-b-
PGMA), methoxypoly(ethylene glycol)-b-(N,N-diethylamino)methyl methacrylate-b-
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poly(glycidyl methacrylate) (MPEG-b-PDMAEMA-b-PGMA), PDEAEMA-b-PGMA and 
MPEG-b-PGMA, were synthesized.  The block copolymers were conjugated to the surface of 
Fe3O4 nanoparticles stabilized with HClO4 via a ligand exchange method.  The authors performed 
drug release studies with MPEG-b-PDEAEMA-b-PGMA-Fe3O4 and MPEG-b-PDMAEMA-b-
PGMA-Fe3O4 nanocarriers encapsulating chlorambucil (CLB), an anti-cancer agent, and 
indomethacin (IND), an anti-inflammatory agent.  Their results showed that upon a decrease in 
pH (below the pKa of each drug), the percentage of drug release increased up to 90% for CLB 
and 70% for IND.  At pH 7.4 the percent of drug release for both IND and CLB was 
approximately 25%.  
             
Concluding remarks 
The ability to alter the biodistribution of a drug by modulating its release profile through 
the use of smart polymers could transform drug delivery from passive controlled release to active 
stimuli-regulated delivery.  Altering the drug biodistribution has the ability to reduce toxicity and 
side effects while improving therapeutic outcomes due to the ability to deliver higher doses of 
drug to the site of interest.  The stimuli-responsive polymers reviewed here serve to provide a 
snapshot of the utility and complexity of polymers that can sense, process, and respond to stimuli 
in modulating the release of a drug.  Stimuli-responsive drug delivery vehicles come in the form 
of polymersomes [111, 112], liposomes [113-115], micelles [116-118], and dendrimers [119, 
120].  All of these systems aim to deliver an effective dose of drug at a specific time and place. 
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Despite many advances, there are still numerous challenges and opportunities that exist to 
translate responsive polymers from the laboratory the clinic.  There is a need to develop 
polymers with greater sensitivity to a more diverse range of stimuli.  In terms of biochemical 
signals or biomarkers, this is usually in the range of nano to picomolar concentrations [121].  
This may require both a highly sensitive sensing mechanism and/or an amplification system to 
elicit a response from the polymer.  In terms of the physical microenvironment, there are only 
minor differences in pH and temperature between diseased and normal tissues.  Therefore, smart 
polymers must be able to accurately sense the changes in their surroundings to target drug 
release.  
There is also a significant opportunity for smart polymers to respond to multiple stimuli.  
Hybrid polymers created in this manner will offer more parameters to tune drug delivery, which 
may be necessary for more complex and dynamic environments.  It is worth noting that in 
addition to drug delivery applications, smart polymers in general have broad applications in 
tissue engineering and regenerative medicine (e.g. as injectable systems for delivery of cells or 
self-regulating scaffolds for cell growth or infiltration), and in actuators (e.g. as smart valves and 
coating in microfluidics or shape memory devices).  Given the continuous development of new 
responsive polymer compositions, we expect increasingly elaborate and versatile drug carriers to 
be introduced in the future. 
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Table 1. Stimuli-sensitive drug delivery. 
 
Stimulus Carrier type Payload Reference 
pH 
PPADK Dexamethasone [45] 
DMAEMA/HEMA Paclitaxel [3] 
PC/DAP liposomes siRNA [51] 
Temperature 
PNIPAm/PLGA Paclitaxel [36] 
MPPC/DPPC/HSPC/DSPEC-PEG-2000 Doxorubicin [54] 
FA/ PDMA/PNIPAm Dipyridamole [57] 
Light 
Cu chlorophyllin/PNIPAm None reported [60] 
Quinone-methide Nile Red [63] 
Au/meso porous silica Paclitaxel [61] 
Ultrasound 
Pluronic P105/ N,N-diethylacrylamide Doxorubicin [66] 
DPPC:DPPE-PEG2000 liposomes Calcein [67] 
Glucose 
poly(methacrylic acid-g-ethylene glycol) 
with glucose oxidase, PNIPAm with 
phenylboronic acid 
Insulin [69-72] 
PNIPAm or carboxymethyl dextran with 
con. A 
None reported [73-74] 
Enzyme 
PEG diacrylate/human neutrophil 
elastase-sensitive peptide 
None reported [75] 
Fibrin/β-nerve growth factor fusion 
proteins 
β-nerve growth factor [76] 
sPLA2-degradable retinoid lipid pro-drug Retinoid lipid pro-drug [77] 
Magnetic 
Magnetite 
Squalenoyl gemcitabine 
(SQdFdC) 
[78] 
Poly[aniline-co-N-(1-one-butyric acid)] 
aniline (SPAnH)/iron oxide 
Epirubicin [79] 
Polylactide/nanocrystalline magnetite Paclitaxel [80] 
Egg-PC/maghemite/PAH/PSS Calcein [81] 
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Table 2 Multiple stimuli-sensitive drug delivery. 
Stimuli Carrier type Payload Reference 
Temperature/pH 
PNIPAm/MAA Vitamin B12 [82]  
PNIPAm/AA Isoniazid [6] 
PNIPAm/AAm/VP Naltrexone [94] 
Light/pH or 
light/temperature  
Polyacrylamide/Salicylideneaniline None reported [101] 
PSS/PAH/Au FITC-dextran [58] 
Magnetic/temperature 
or magnetic/pH  
PEO/PPO/PEO/Fe2O3 Ibuprofen and Eosin Y [102] 
PNIPAm/γ-Fe2O3/SiO2 None reported [105] 
MPEG-b-PDEAEMA-b-PGMA, 
MPEG-b-PDMAEMA-b-PGMA, 
PDEAEMA-b-PGMA and MPEG-
b-PGMA/ Fe3O4  
Chlorambucil and 
indomethacin 
[109] 
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LEGENDS OF FIGURES 
 
Figure 1.  Transmission electron microscope image of DMAEMA/HEMA nanoparticles used for 
drug delivery.  Scale bar is 500 nm [3].   
 
Figure 2.  Triggered paclitaxel release was observed by incubating 10/90 (mol/mol) 
DMAEMA/HEMA nanoparticles crosslinked with 3 mol% TEGDMA for 2 hours at pH 7.4 
(black triangle) followed by a reduction in pH to either 6.8 (black circle), 7.0 (black square), or 
7.2 (black diamond) for 4 hours.  The error is the standard deviation of the mean, where n = 3 [3].  
 
Figure 3.  Schematic illustration of the delivery of pH-sensitive gene carriers.  For example, the 
DMAEMA/HEMA nanoparticle releases DNA in the low pH endosome [49]. 
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